BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23794710)

  • 1. RIP2 activity in inflammatory disease and implications for novel therapeutics.
    Jun JC; Cominelli F; Abbott DW
    J Leukoc Biol; 2013 Nov; 94(5):927-32. PubMed ID: 23794710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.
    Goncharov T; Hedayati S; Mulvihill MM; Izrael-Tomasevic A; Zobel K; Jeet S; Fedorova AV; Eidenschenk C; deVoss J; Yu K; Shaw AS; Kirkpatrick DS; Fairbrother WJ; Deshayes K; Vucic D
    Mol Cell; 2018 Feb; 69(4):551-565.e7. PubMed ID: 29452636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Abbott DW; Wilkins A; Asara JM; Cantley LC
    Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
    Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
    Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MEKK4 sequesters RIP2 to dictate NOD2 signal specificity.
    Clark NM; Marinis JM; Cobb BA; Abbott DW
    Curr Biol; 2008 Sep; 18(18):1402-8. PubMed ID: 18775659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 enhances Nod1/2-mediated inflammatory cytokine production by promoting Rip2 phosphorylation.
    Yan R; Liu Z
    Protein Cell; 2017 Jan; 8(1):55-66. PubMed ID: 27830463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.
    Homer CR; Kabi A; Marina-García N; Sreekumar A; Nesvizhskii AI; Nickerson KP; Chinnaiyan AM; Nuñez G; McDonald C
    J Biol Chem; 2012 Jul; 287(30):25565-76. PubMed ID: 22665475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
    Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
    J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIP2 promotes FcγR-mediated reactive oxygen species production.
    Shehat MG; Cardona OA; Aranjuez GF; Jewett MW; Tigno-Aranjuez JT
    J Biol Chem; 2019 Jun; 294(26):10365-10378. PubMed ID: 31113864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
    Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
    Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2-RIP2 contributes to the inflammatory responses of mice in vivo to Streptococcus pneumoniae.
    Zheng Y; Shang F; An L; Zhao H; Liu X
    Neurosci Lett; 2018 Apr; 671():43-49. PubMed ID: 29408491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
    Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
    Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation NODs to Antagonists of RIP2-XIAP Interaction.
    Xia S; Fu TM; Wu H
    Mol Cell; 2018 Feb; 69(4):535-536. PubMed ID: 29452633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses.
    Tigno-Aranjuez JT; Asara JM; Abbott DW
    Genes Dev; 2010 Dec; 24(23):2666-77. PubMed ID: 21123652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.
    Wu J; Zhang Y; Xin Z; Wu X
    Mol Immunol; 2015 Apr; 64(2):235-43. PubMed ID: 25549945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tandem CARDs of NOD2: intramolecular interactions and recognition of RIP2.
    Fridh V; Rittinger K
    PLoS One; 2012; 7(3):e34375. PubMed ID: 22470564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP mediates NOD signaling via interaction with RIP2.
    Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.